|  | | 
 | () | | | () | | | () | | | () | | | () | | | () | | | () | | | () | | | () | | | () | | | () | | | () | | | () | | | () | | | () | |
|
| | | 
| |  | |
News Hub Callendar
| < January 2009 | | Su | M | T | W | T | F | S | | | 1 | 2 | 3 |
| 4 | 5 | 6 | 7 | 8 | 9 | 10 |
| 11 | 12 | 13 | 14 | 15 | 16 | 17 |
| 18 | 19 | 20 | 21 | 22 | 23 | 24 |
| 25 | 26 | 27 | 28 | 29 | 30 | 31 |
|
| |
|
| | New Survey Sheds Light on Mistaken Identities of Interstitial Cystitis |
|
date: Aug 22nd 2006 10:05
page: 1 | 2 | 3
Important Safety Information
ELMIRON® has been shown to be well tolerated. The most common side effects were blood in stool, diarrhea, nausea, hair loss, headache, rash, upset stomach, abdominal pain, liver function abnormalities and dizziness. When side effects did occur, they were generally mild and usually did not interfere with continuing treatment. Hair loss, when it occurred, was almost always limited to a single area of the scalp, and grew back when ELMIRON® was discontinued. ELMIRON® is a weak anticoagulant (blood thinner), which may increase bleeding. Call your doctor if you will be undergoing surgery or will begin taking anticoagulant therapy such as warfarin, heparin, high doses of aspirin or anti-inflammatory drugs such as ibuprofen. For full Prescribing Information go to www.orthoELMIRON.com.
About Ortho Women s Health & Urology
Ortho Women s Health & Urology, a Division of Ortho-McNeil Pharmaceutical, Inc., is celebrating 75 years of partnering with women. As a leader in the fields of women s health and urology, Ortho Women s Health & Urology is committed to helping people live healthier lives and to meeting the needs of providers and patients with products such as ORTHO EVRA® (norelgestromin/ethinyl estradiol transdermal system), ORTHO TRI-CYCLEN® LO (norgestimate/ethinyl estradiol), DITROPAN XL® (oxybutynin chloride) and ELMIRON® (pentosan polysulfate sodium). For more information on these products, birth control, bladder health or general women s health issues, please visit www.orthowomenshealth.com.
* The survey was conducted by telephone with a national sample of 520 women ages 25-50 from May 3-18, 2006, by ICR. The margin of error was plus or minus 4.3 percentage points. This survey was sponsored by Ortho Women s Health & Urology, a Division of Ortho-McNeil Pharmaceuticals, Inc.
page: 1 | 2 | 3
article 'New Survey Sheds Light on Mistaken Identities of Interstitial Cystitis' source is Johnson & Johnson, visit source site:
Articles by information source
News and articles by category
News and articles by day |
|
